超越肠道:甲状腺素吸收不良,药理动力学和输送
Lawrence Siu-Chun Law1,2, Nicholas Wei Xiang Kuu3,4, Melissa Hui Ting Leong1,2
1Endocrinology Division, Department of Medicine, National University Hospital, Singapore.
The Journal of clinical endocrinology and metabolism
|January 23, 2026
概括
难治性甲状腺功能低下症的治疗需要区分真正的吸收不良与不坚持. 最近的证据支持快速吸收协议和门利沃西,包括皮下注射,用于具有挑战性的病例.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 耐药性原发性甲状腺功能低下症涉及甲状腺刺激激素 (TSH) 的升高,尽管高剂量的levothyroxine.
- 区分真正的吸收不良与伪吸收不良 (不坚持) 对于有效的患者管理至关重要.
- 最近的框架和审查强调需要更新的策略来管理复杂的Levothyroxine吸收问题.
研究的目的:
- 综合最近的证据 (2023年以后) 关于耐火性甲状腺功能低下症的管理.
- 介绍一些临床案例,说明甲素吸收方面的挑战和解决方案.
- 讨论新兴的勒沃西素配方和使用途径.
主要方法:
- 自2023年以来,PubMed搜索发现了41个相关出版物.
- 审查病例报告,药理学研究和临床研究.
- 分析了两个涉及耐火性甲状腺功能低下症和吸收问题的临床病例.
主要成果:
- 案例1:在患有先天性甲状腺功能低下症的患者中发现了伪吸收不良,快速吸收协议证明有效.
- 案例2:在患有乳头甲状腺癌和功能衰竭的患者中确诊了真正的吸收不良,需要输入肠道 (皮下) 利沃西.
- 没有标准化吸收测试存在于肠道Levothyroxine,但药理动力学原则可以指导评估.
结论:
- 快速口服levothyroxine吸收协议提供可行的替代方案.
- 亲肠道甲素,特别是皮下,对于严重吸收不良的患者来说是一个可行的选择.
- 需要进行进一步的研究来验证亲体利沃西配方的安全性和药理动力学.
相关概念视频
Pharmacokinetics: Overview
9.3K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
9.3K
Pharmacokinetic Models: Overview
2.0K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.0K
Nonlinear Pharmacokinetics: Overview
1.1K
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
1.1K
Nonlinear Pharmacokinetics: Causes of Nonlinearity
719
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
719
Biopharmaceutics and Pharmacokinetics: Overview
3.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.8K
Cholinergic Antagonists: Pharmacokinetics
921
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
921


